Integrated Traditional Chinese and Western Medicine Therapy for Myocardial Infarction
摘要
Myocardial infarction (MI) is an acute and critical cardiovascular disease characterized by acute myocardial ischemia and necrosis due to coronary artery occlusion. It has the characteristics of high morbidity, rapid progression, and high mortality, seriously threatening human life and health. Western medicine has mature treatment systems for MI, such as reperfusion therapy, antiplatelet aggregation, and lipid-lowering therapy, which can quickly relieve acute symptoms but have limitations in improving long-term prognosis and reducing complications. Traditional Chinese Medicine (TCM), based on the holistic concept and syndrome differentiation and treatment, has unique advantages in regulating qi and blood, unblocking collaterals, and promoting myocardial repair. Integrated Traditional Chinese and Western Medicine (TCM-WM) therapy combines the advantages of both, complementing each other to optimize the treatment effect.
参考
[2]ZhaoZ ,Wang X ,Wang S , et al. Study on the clinical assessment of integrated rehabilitation of Traditional Chinese Medicine and western medication for acute myocardial infarction[J].Medicine,2020,99(34):e21592-e21592.
[3]Lei W ,Minzhou Z ,Liheng G , et al. Clinical pathways based on integrative medicine in chinese hospitals improve treatment outcomes for patients with acute myocardial infarction: a multicentre, nonrandomized historically controlled trial.[J].Evidence-based complementary and alternative medicine: eCAM,2012,2012821641.
艺博科研学术出版社致力于保障作者的版权和所有信息,确保这些权益得到法律的充分保护。无论您是否选择在我们出版社发表文章,我们都会要求每一位员工遵循行业内最高的道德标准、承担责任,并履行法律义务。
为了进一步保护作者的权益,我们在官网上提供了详尽的版权协议信息,供您查阅。在文章的再使用权利方面,艺博科研学术出版社持开放态度,严格遵守CC BY-NC 4.0出版条例。这一条例不仅为作者提供了版权保护,也满足了开放获取学术出版协会(OASPA)对使用权利的标准。
对于那些希望进一步保护自己文章的作者,我们还提供了CC BY-NC条例服务。根据作者选择的CC条例,文章的原始版权和再使用权利将在文章中明确展示。这样的做法不仅尊重了作者的知识产权,也促进了学术成果的合理传播和使用